>>Signaling Pathways>> GPCR/G protein>> Ras>>MLS000532223

MLS000532223

Catalog No.GC61076

MLS000532223은 16μM에서 120μM 범위의 EC50 값을 갖는 Rho 계열 GTPase의 고친화성 선택적 억제제입니다. MLS000532223은 여러 GTPase에 대한 GTP 바인딩을 방지합니다.

Products are for research use only. Not for human use. We do not sell to patients.

MLS000532223 Chemical Structure

Cas No.: 16616-39-0

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$297.00
재고 있음
5mg
US$270.00
재고 있음
10mg
US$405.00
재고 있음
50mg
US$1,260.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com


고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

MLS000532223 is a high affinity, selective inhibitor of Rho family GTPases, with EC50 ranging from 16 μM to 120 μM. MLS000532223 prevents GTP binding to several GTPases. Small GTPases are key regulators of cellular activity [1].

MLS000532223 prevents GTP binding to several GTPases in a dose-dependent manner[1].MLS000532223 modulates Rho-family GTP-binding kinetics[1].MLS000532223 is active in cell-based assays and inhibits EGF-stimulated Rac 1 activation[1].MLS000532223 inhibits actin rearrangements and changes in cell morphology that are downstream of Rho family GTPase activation[1].MLS000532223 (10 μM) modulates actin remodeling in mast cells[1].MLS000532223 (10 μM) inhibits ligand-stimulated β-hexosaminidase secretion of RBL cells[1].

[1]. Zurab Surviladze, et al. Identification of a Small GTPase Inhibitor Using a High-Throughput Flow Cytometry Bead-Based Multiplex Assay. J Biomol Screen. 2010 Jan;15(1):10-20.

리뷰

Review for MLS000532223

Average Rating: 5 ★★★★★ (Based on Reviews and 13 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MLS000532223

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.